morphosys.com (MOR) - Wutah pendapatan triwulanan

Logo korporat perusahaan MorphoSys Corp (MOR)

MorphoSys AG (MOR) , a German leader in targeted antibody development, was acquired by a pharma behemoth to accelerate pelabresib releases. Quarterly revenue growth dynamics help verify the fundamental stability of the business, while the value of -55.60 reflects this status. The company's stability relies on partnerships with global corporations and a portfolio of approved drugs for the therapy of solid tumors.

MOR Tingkat wutah pendapatan sajrone kuartal MorphoSys Corp (04.07.2022 - 10.08.2024)

Rincian analitis lan laporan data perusahaan MorphoSys Inc (MOR)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis fundamental perusahaan:MorphoSys AG - MOR
Barang unggulan MorphoSys

An analysis of the quarterly revenue growth trend on GURU.Markets allows for a comparison of MorphoSys AG (MOR) operational scale with the commercialization dynamics of its patent-protected antibodies. This indicator measures the percentage change in sales for the current quarter compared to the same period last year, serving as a marker of the business's ability to outpace inflation and navigate stringent FDA regulatory oversight to capitalize on its technological advantages.

Perusahaan pesaing

BeiGene Oncology - Wutah pendapatan triwulanan|HALO: Wutah pendapatan kuartal marang kuartal|Revolution Medicines Corp (RVMD) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Ascentage Pharma Group International (AAPG)|Wutah pendapatan kuartal marang kuartal CG Oncology, Inc.|Tingkat wutah pendapatan sajrone kuartal UroGen Pharma Corp URGN|Wutah pendapatan triwulanan BCAX|Personalis, Inc. - Wutah dodolan kuartal marang kuartal|Erasca - Wutah dodolan triwulanan|Tambahing pendapatan triwulanan DCTH|YMAB: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Aura Corp|CADL: Wutah pendapatan triwulanan|ARAY - Tingkat wutah dodolan sajrone kuartal|SLS (SELLAS Life Sciences Group, Inc.) - Wutah pendapatan triwulanan|ACTU: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal citiusonc.com (CTOR)|Tingkat wutah dodolan sajrone kuartal TuHURA Biosciences|Wutah pendapatan kuartal marang kuartal Protara Therapeutics TARA|Fate Therapeutics (FATE) - Tingkat wutah pendapatan sajrone kuartal|WHWK - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal TScan Therapeutics Inc|championsoncology.com (CSBR) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan kuartal marang kuartal XBIT|Wutah dodolan triwulanan CVM|Wutah dodolan kuartal marang kuartal OSTX (OS Therapies Incorporated)|Wutah pendapatan triwulanan RADX|ARTV: Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan triwulanan ANL (Adlai Nortye Ltd)|VERU - Wutah dodolan triwulanan|tempesttx.com - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan XLO (xiliotx.com)|RENB: Wutah pendapatan triwulanan|Wutah dodolan triwulanan Mural Oncology plc|Wutah pendapatan kuartal marang kuartal Kairos Pharma Inc|OKUR: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan GDTC|CRIS (Curis) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal apollomicsinc.com APLM|THAR: Wutah dodolan kuartal marang kuartal|advanbiomed.com - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan GNPX (Genprex, Inc)|Calidi Biotherapeutics Inc. (CLDI) - Wutah pendapatan kuartal marang kuartal|Sunshine Biopharma Inc. (SBFM) - Wutah pendapatan triwulanan|XBIO (Xenetic Bio) - Wutah pendapatan triwulanan|Salarius Pharmaceuticals Inc (SLRX) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan PPBT|Wutah pendapatan triwulanan American Oncology Network Inc (AONC)|Wutah pendapatan triwulanan BGNE (BeiGene Ltd.)|Owah-owahan dodolan kuartal marang kuartal CKPT (Checkpoint Therapeutics)|ELEV - Wutah pendapatan kuartal marang kuartal|ICAD (iCAD Inc.) - Wutah dodolan kuartal marang kuartal|Ikena (IKNA) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan triwulanan Notable Labs, Ltd.|Wutah pendapatan kuartal marang kuartal viracta.com|NAYA: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Ascentage Pharma Group Ltd (AAPGV)